Abstract: Sulfonic acid salts, and particularly the methanesulfonic acid salt of 6-amino-1,5-dihydro-4H-imidazo-[4,5-c]pyridin-4-one (3-deazaguanine) possess unexpected solubility in water and are thus useful in preparing pharmaceutical compositions having the requisite stability, clarity, and potency for parenteral administration.
Abstract: Certain trans-6-[[(substituted)quinolinyl]ethyl]-and ethenyl]tetrahydro-4-hydroxypyran-2-ones and the corresponding dihydroxy ring-opened acids derived therefrom are potent inhibitors of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) and are useful as hypocholesterolemic and hypolipidemic agents.
Type:
Grant
Filed:
December 7, 1987
Date of Patent:
August 2, 1988
Assignee:
Warner-Lambert Company
Inventors:
Joseph A. Picard, Bruce D. Roth, Drago R. Sliskovic
Abstract: Certain 2-substituted-[2-substituted-amino]-N-arylalkyl-3-[indol-3-yl]propanamides demonstrate activity as appetite suppressants. The compounds, pharmaceutical compositions, and a method of suppressing appetite are disclosed.
Abstract: Certain trisubstituted anilides of oleic, linoleic, and linolenic acid are potent inhibitors of the enzyme acyl-CoA:cholesterol acyltransferase and are thus useful agents for inhibiting the intestinal absorption of cholesterol.
Abstract: Certain substituted 1,2,3,6-tetrahydro- and 1,2,5,6-tetrahydropyridine-3-carboxylic acids, esters, and amides possessing muscarinic binding activity, having utility for the treatment of the symptoms of senile cognitive decline disclosed. Pharmaceutical compositions and a pharmaceutical method of treatment are also disclosed.
Type:
Grant
Filed:
February 18, 1986
Date of Patent:
May 17, 1988
Assignee:
Warner-Lambert Company
Inventors:
Donald E. Butler, John H. Dodd, Walter H. Moos, Haile Tecle
Abstract: Certain substituted amides of saturated fatty acids are potent inhibitors of the enzyme acyl-CoA:cholesterol acyltransferase and are thus useful agents for inhibiting the intestinal absorption of cholesterol.
Type:
Grant
Filed:
October 1, 1987
Date of Patent:
May 10, 1988
Assignee:
Warner-Lambert Company
Inventors:
Milton L. Hoefle, Ann Holmes, Bruce D. Roth
Abstract: Substituted trans-1,2-diaminocyclohexyl amide compounds demonstrating selective opioid receptor binding possess utility as analgesic, diuretic, and psychotherapeutic agents. A method of preparing the compounds, pharmaceutical compositions employing the compounds, and a method of alleviating pain employing the compounds are also disclosed.
Abstract: Acids, esters, imine acids, imine esters, and imine amides derived from 6-formyl-4,7,9-trihydroxy-1-phenazinecarboxylic acid, methyl ester and from 6-formyl-4,7,9-trihydroxy-8-methyl-1-phenazinecarboxylic acid, methyl ester demonstrate anti-microbial and antineoplastic activity.A purified strain of Streptomyces galanosa, NRRL 15738, is capable of producing 6-formyl-4,7,9-trihydroxy-8-methyl-1-phenazinecarboxylic acid, methyl ester in isolable quantities from a fermentation broth containing assimilable sources of carbon and nitrogen.
Abstract: Substituted phenoxy-, 1-, and 2-naphthalenyloxy-, indenyl-, indolyl-, benzofuranyl-, and benzo[b]thiofuranylcarboxamides of 7,8-(substituted-diamino)-1-oxaspiro[4.5]decanes are useful as analgesic agents.A method of making the compounds, pharmaceutical compositions employing the compounds, and a method of alleviating pain in warm-blooded animals are also disclosed.
Abstract: Disubstituted 7-pyrrolidinoquinoline- and -naphthyridine-3-carboxylic acids as antibacterial agents are described as well as methods for their manufacture, formulation, and use in treating bacterial infections.
Type:
Grant
Filed:
June 22, 1987
Date of Patent:
April 5, 1988
Assignee:
Warner-Lambert Company
Inventors:
John M. Domagala, Susan E. Prugh, Joseph P. Sanchez, Marjorie S. Solomon
Abstract: Certain trans-6-[2-[2-(substituted-phenyl)-3- (or 4-)heteroaryl-5-substituted-1H-pyrrol-1-yl]ethyl]tetrahydro-4-hydroxy-2H-p yran-2-ones and the corresponding lactone-ring-opened acids are potent inhibitors of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG CoA reductase) and are thus useful hypolipidemic or hypocholesterolemic agents. Pharmaceutical compositions containing such compounds, and a method of inhibiting the biosynthesis of cholesterol employing such pharmaceutical compositions are also disclosed.
Abstract: A strain of Actinomadura sp., NRRL 15758, is capable of producing the CL-1724 complex of antibiotic substances in isolable quantities under conditions of aerobic fermentation in a culture medium containing assimilable sources of carbon and nitrogen.
Abstract: A purified isolate of an actinomycete identified as ATCC 39366 is capable of producing the antimicrobial compound CL-1957E which also exhibits antitumor properties.The antimicrobial compound CL-1957E is produced by cultivating isolate ATCC 39366 under aerobic conditions in a culture medium containing assimilable sources of carbon and nitrogen until a substantially quantity of the CL-1957E compound is produced, and subsequently isolating the CL-1957E compound.The antibiotic compound CL-1957E and pharmaceutical compositions comprising this substance together with a pharmaceutically acceptable carrier is also disclosed, as are methods of treating microbial infections and tumors in mammals, employing these pharmaceutical compositions.
Type:
Grant
Filed:
March 3, 1986
Date of Patent:
February 16, 1988
Assignee:
Warner-Lambert Company
Inventors:
Richard H. Bunge, James C. French, Timothy R. Hurley, Neil E. Willmer
Abstract: Certain disubstituted pyrimidineamides of oleic and linoleic acids are potent inhibitors of the enzyme acyl-CoA:cholesterol acyltransferase and are thus useful agents for inhibiting the intestinal absorption of cholesterol.
Abstract: A novel method of producing 4,5-dihydro-6-(substituted)phenyl-5-methyl-3(2H)-pyridazinone compounds and the corresponding pharmaceutically acceptable salt compounds is provided as well as pharmaceutical compositions containing one or more of the compounds as active components of the compositions for their pharmacological activity, particularly their cardiotonic and/or antihypertensive activity.Said 5-methylpyridazinone compounds have greatly improved cardiotonic activity in vivo that causes, for example, a significant increase in myocardial contractility in the dog. Said compounds also cause a decrease in blood pressure in the spontaneously hypertensive rat. Said compounds are produced by a stepwise procedure in which one reacts a substituted morpholineacetonitrile with crotononitrile to obtain the corresponding 4-(substituted)-.beta.-methyl.gamma.-oxobenzenebutanoic acid and reacts the latter acid with hydrazine to provide the 4,5-dihydro-6-(substituted)phenyl-5-methyl-3(2 ,uns/H/ )-pyridazinone product.
Abstract: Certain substituted amides of saturated fatty acids are potent inhibitors of the enzyme acyl-CoA:cholesterol acyltransferase and are thus useful agents for inhibiting the intestinal absorption of cholesterol.
Type:
Grant
Filed:
February 24, 1987
Date of Patent:
December 29, 1987
Assignee:
Warner-Lambert Company
Inventors:
Milton L. Hoefle, Ann Holmes, Bruce D. Roth
Abstract: 2'-Chloropentostatin is a potent inhibitor of the enzyme adenosine deaminase and possesses utility as an agent for potentiating the activity of antiviral agents for the treatment of DNA viruses which agents contain an adenine moiety, such as 9-(beta-D-arabinosyl)adenine. A pure strain of actinomycete, designated ATCC 39365 which is capable of producing 2'-chloropentostatin, a method of producing 2'-chloropentostatin by aerobic fermentation, and pharmaceutical compositions including 2'-chloropentostatin are also disclosed.
Type:
Grant
Filed:
November 8, 1985
Date of Patent:
December 15, 1987
Assignee:
Warner-Lambert Company
Inventors:
John P. Schaumberg, Gerard C. Hokanson, James C. French, Josefino B. Tunac, Marjorie A. Underhill
Abstract: Certain O-substituted 1-(1,2,3,6-tetrahydro-1-methyl-3-pyridinyl)ketone oximes and O-substituted 1-(1,2,3,6-tetrahydro-4-pyridinyl)ketone oximes are useful as analgesic agents or agents for the treatment or amelioration of the symptoms of cerebral insufficiency characterized by decreased central acetylcholine production or release.Pharmaceutical compositions containing the compounds and methods of using the compositions in a pharmaceutical method are also disclosed.
Type:
Grant
Filed:
December 8, 1986
Date of Patent:
December 1, 1987
Assignee:
Warner-Lambert Company
Inventors:
Stephen C. Bergmeier, David A. Downs, Walter H. Moos, David W. Moreland, Haile Tecle
Abstract: Substituted 2,5-dihydro- and 2,4,4a,5-tetrahydro-3H-indeno[1,2-c]pyridazin-3-ones and pharmaceutically acceptable salts thereof are useful as cardiotonic and antihypertensive agents.